Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Jincheng Taier Pharmaceutical is a specialized pharmaceutical company based in China, operating as a core subsidiary of Shandong Jincheng Pharmaceutical Group. The company focuses on the research, development, and manufacturing of high-quality medications, with a strong market presence in gynecology, dermatology, and anti-infective therapies. Its flagship products include Clindamycin Phosphate Vaginal Gel and other treatments for women's health under the well-known "Langyi" brand. The company maintains modern manufacturing facilities in Beijing that comply with national GMP standards and serves both domestic and international markets. Following its acquisition by Jincheng Pharmaceutical in 2016, it has integrated its R&D and sales capabilities to provide comprehensive healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Jincheng Taier Pharmaceutical.